PUBLISHER: The Business Research Company | PRODUCT CODE: 1938753
PUBLISHER: The Business Research Company | PRODUCT CODE: 1938753
A veterinary stereotactic radiosurgery system is a form of external radiation therapy that precisely positions the patient while delivering a single, high dosage of radiation to a tumor.
The primary types of veterinary stereotactic radiosurgery systems encompass microsurgical instrumentation, optical or viewing instruments, and other related products. Microsurgical instrumentation refers to hand-held surgical tools designed specifically for microsurgical and delicate procedures, facilitating the handling of fragile tissues, tendons, and blood vessels. Various modalities involved in these systems include gamma knife, linear accelerator, particle beam radiation therapy, and cyber knife, which are utilized for applications in canine, feline, and other veterinary scenarios. Different end users for these systems include hospitals, contract research organizations (CROs), and other relevant entities.
Tariffs have impacted the veterinary stereotactic radiosurgery system market by increasing costs of imported microsurgical instruments, imaging systems, and radiation delivery equipment, affecting hospital and CRO budgets. Companion animal oncology segments in North America and Europe are most affected due to dependence on high-precision imported devices. Positively, tariffs are encouraging local manufacturing, innovation in cost-effective treatment systems, and adoption of domestic alternatives, helping strengthen regional supply chains and reduce long-term dependency on imports.
The veterinary stereotactic radiosurgery system market research report is one of a series of new reports from The Business Research Company that provides veterinary stereotactic radiosurgery system market statistics, including veterinary stereotactic radiosurgery system industry global market size, regional shares, competitors with a veterinary stereotactic radiosurgery system market share, detailed veterinary stereotactic radiosurgery system market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary stereotactic radiosurgery system industry. This veterinary stereotactic radiosurgery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The veterinary stereotactic radiosurgery system market size has grown rapidly in recent years. It will grow from $3.28 billion in 2025 to $3.69 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to rising incidence of cancer in companion animals, advancements in veterinary oncology, growth of veterinary specialty hospitals, increasing availability of imaging technologies, demand for precision radiation therapy.
The veterinary stereotactic radiosurgery system market size is expected to see rapid growth in the next few years. It will grow to $5.9 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to development of high-precision radiation delivery systems, integration of AI in treatment planning, growth in canine and feline oncology programs, increasing investments in veterinary cancer care, expansion of contract research organizations (CROs) supporting animal oncology. Major trends in the forecast period include increasing adoption of stereotactic radiosurgery in veterinary oncology, development of minimally invasive treatment options, integration of advanced imaging for precise tumor targeting, expansion of specialized veterinary cancer centers, rising awareness of pet cancer treatment options.
The growing pet population is expected to drive the growth of the veterinary stereotactic radiosurgery system market going forward. Pet population refers to the total number of domesticated animals, such as dogs, cats, and other pets, that are kept and cared for by people within a specific area or community. The pet population is increasing as more households adopt animals for companionship, leading to a larger number of pets under care. Veterinary stereotactic radiosurgery systems support pet health by providing precise, non-invasive treatment for tumors and other serious conditions, improving recovery outcomes and overall quality of life. For example, in July 2025, according to the World Animal Foundation (WAF), a US-based animal welfare organization, pet ownership in the U.S. reached 71% of households, up from 66% in 2023-2024. Therefore, the rise in the pet population is fueling the growth of the veterinary stereotactic radiosurgery system market.
Leading companies operating in the veterinary stereotactic radiosurgery system market are focusing on technological advancements, such as AI-driven image-guided treatment delivery platforms, to strengthen their competitive position. AI-driven image-guided treatment delivery platforms are integrated digital systems that combine artificial intelligence with imaging and robotic controls to plan, prescribe, and accurately deliver stereotactic radiation therapies, improving treatment precision, reducing procedure times, and enhancing clinical workflow efficiency. For instance, in September 2024, BluePearl Veterinary Partners LLC, a US-based veterinary care provider, introduced the CyberKnife System for veterinary use, featuring a robotic linear accelerator capable of delivering high-energy photon beams from multiple angles, real-time imaging guidance to minimize exposure to healthy tissue, and sub-millimeter targeting precision for complex tumors. This technology expands access to advanced oncology care for animals and strengthens specialty clinical capabilities, though it requires significant investment in training and infrastructure.
In November 2025, Empyrean Medical Systems Inc., a US-based medical technology company, formed a strategic partnership with Pathway Vet Alliance LLC to deploy its Sirius advanced radiation platform and broaden access to precision stereotactic radiation therapy for pets. Through this collaboration, Empyrean aims to introduce its Sirius platform into the veterinary oncology market, providing human-grade precision stereotactic radiation therapy for pets battling cancer. Pathway Vet Alliance LLC is a US-based veterinary services network that offers access to the Veterinary Stereotactic Radiosurgery (SRS) system.
Major companies operating in the veterinary stereotactic radiosurgery system market are PetCure Oncology, Elekta AB, Accuray Incorporated, Varian Medical Systems Inc., ZAP Surgical Systems Inc., Brainlab AG, Best Medical International Inc., Mevion Medical Systems Inc., Vision RT Limited, ViewRay Inc., Xstrahl Ltd., Avante Health Solutions, Medtronic plc, RaySearch Laboratories, Best Theratronics Ltd., MASEP Medical Science Technology Development Co Ltd, RefleXion Medical Inc., CIVCO Radiotherapy, Xcision Medical Systems, GammaVet, RadVet, ALCEN, Isoray Inc., PTW Freiburg GmbH, Ion Beam Applications SA, Nanovi Radiotherapy AS
North America was the largest region in the veterinary stereotactic radiosurgery system market in 2025. The regions covered in the veterinary stereotactic radiosurgery system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the veterinary stereotactic radiosurgery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
A veterinary stereotactic radiosurgery system market includes revenues earned by entities by veterinary stereotactic radiosurgery system that are used in the treatment of cancers and other issues that affect the brain, neck, lungs, liver, spine, and other areas of the body of pets and animals. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Stereotactic Radiosurgery System Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses veterinary stereotactic radiosurgery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for veterinary stereotactic radiosurgery system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary stereotactic radiosurgery system market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.